# Xenon Pharmaceuticals Inc.: Form 8-K, filed Apr 13, 2026

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2026-04-13
- Accepted by EDGAR: Apr 13, 2026, 16:01 ET
- Period: 2026-04-07
- Accession: 0001193125-26-152834
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000119312526152834/xene-20260407.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000119312526152834/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000119312526152834/xene-20260407.htm

Filed Apr 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-152834. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.
